Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,072 | 32,632 | 120,888 | 18,385 | 14,104 |
| Marketable Securities | 137,548 | 135,721 | 13,597 | 26,712 | 4,205 |
| Receivables | 2,320 | 10,610 | 6,899 | 2,581 | 3,801 |
| Other current assets | 0 | 0 | 0 | 171 | 1,558 |
| TOTAL | $287,257 | $188,158 | $145,001 | $50,408 | $26,109 |
| Non-Current Assets | |||||
| PPE Net | 32,342 | 19,737 | 14,251 | 11,456 | 6,857 |
| Investments And Advances | 0 | 0 | 0 | 6,233 | 0 |
| Intangibles | 63,858 | 67,189 | 74,957 | 33,141 | 33,141 |
| Other Non-Current Assets | 2,581 | 918 | 916 | 1,107 | 469 |
| TOTAL | $98,781 | $87,844 | $90,124 | $51,937 | $40,467 |
| Total Assets | $386,038 | $276,002 | $235,125 | $102,345 | $66,576 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 58 | N/A |
| Accounts payable and accrued liabilities | 11,889 | 12,908 | 5,985 | 3,228 | 2,645 |
| Accrued Expenses | 26,734 | 19,397 | 10,411 | 7,275 | 4,528 |
| Other current liabilities | 3,007 | 70 | 379 | 267 | N/A |
| TOTAL | $76,494 | $34,116 | $18,122 | $11,675 | $7,579 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 395 | 1,004 | 990 | 300 |
| Deferred Revenues | 34,469 | 1,138 | 470 | 690 | 386 |
| Other Non-Current Liabilities | 12,704 | 1,639 | 1,763 | 0 | 368 |
| TOTAL | $16,875 | $12,268 | $13,769 | $10,430 | $5,148 |
| Total Liabilities | $93,369 | $46,384 | $31,891 | $22,105 | $12,727 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,515 | 11,969 | 10,453 | 7,397 | 6,079 |
| Common Shares | 2,704 | 2,393 | 2,091 | 1,484 | 1,175 |
| Retained earnings | -650,030 | -493,093 | -410,146 | -358,163 | -329,656 |
| Other shareholders' equity | -9,574 | -7,055 | 389 | -20 | 382 |
| TOTAL | $292,669 | $229,618 | $203,234 | $80,240 | $53,849 |
| Total Liabilities And Equity | $386,038 | $276,002 | $235,125 | $102,345 | $66,576 |